Role of Galectin-3 in Breast Cancer Metastasis
Autor: | Timothy R. Billiar, Yong J. Lee, Young K. Song |
---|---|
Rok vydání: | 2002 |
Předmět: |
medicine.medical_specialty
biology Transfection medicine.disease Pathology and Forensic Medicine Metastasis Nitric oxide Nitric oxide synthase chemistry.chemical_compound Endocrinology chemistry Galectin-3 Tumor progression Cell culture Internal medicine medicine biology.protein Cancer research Cytotoxicity |
Zdroj: | The American Journal of Pathology. 160:1069-1075 |
ISSN: | 0002-9440 |
Popis: | We investigated the role of galectin-3 in metastasis of human breast carcinoma BT549 cells using the experimental liver metastasis model. Underlying mechanisms were then elucidated using the liver/tumor co-culture and cell culture systems. After intrasplenic injection, galectin-3 cDNA transfected BT549 cells (BT549 gal-3 wt ) formed metastatic colonies in the liver, while galectin-3 null BT549 cells (BT549 par ) did not, demonstrating that galectin-3 enhances metastatic potential. More than 90% of BT549 gal-3 wt cells survived after 24 hours-co-culture with the liver fragments isolated following ischemia treatment. In contrast, more than half of BT549 par cells showed metabolic death following co-culture with the liver fragments. When the liver from inducible nitric oxide synthase (iNOS) knockout mice was used, no cytotoxicity to BT549 par cells was observed. Thus, iNOS exerts cytotoxicity on BT549 par cells and galectin-3 can protect against iNOS-induced cytotoxicity. BT549 gal-3 wt also exhibited enhanced survival against peroxynitrite (up to 400 μmol/L) in vitro . A single mutation in the NWGR motif of galectin-3 obliterated both metastatic capability and cell survival, indicating that the antiapoptotic function of galectin-3 is involved in enhanced metastasis. In conclusion, galectin-3 enhances the metastatic potential of BT549 cells through resistance to the products of iNOS, possibly through its bcl-2-like antiapoptotic function. |
Databáze: | OpenAIRE |
Externí odkaz: |